Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Summary by 6ix AI
The certificate indicates that all shares are held in dematerialized form and there were no requests for rematerialization or dematerialization during the reporting period. The document is submitted to the Corporate Compliance Department of BSE Limited for record-keeping purposes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we hereby enclosed a copy of the Confirmation Certificate received from Bigshare Services Private Ltd., the Registrar and Share Transfer Agent (RTA) of the Company, on 04.04.2026, for the Quarter ended March 31, 2026. We request you to kindly take above on the record. DOPESH RAJA MULAKALA MANAGING DIRECTO
Earlier from Vanta Bioscience
- Vanta Bioscience Ltd. Press Release Mar 24 2026
- Closure of Trading Window
- Vanta Bioscience Ltd. Press Release Mar 11 2026
- Clarification On Movement In Price
- Vanta Bioscience Ltd. Press Release Nov 14 2025
Later from Vanta Bioscience
- Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026
- Vanta Bioscience Ltd. Press Release May 26 2026
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026
- Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026
- Vanta Bioscience Ltd. Press Release May 30 2026
Follow Vanta Bioscience into a list and get an email when it puts out news.
Follow Vanta Bioscience